CompletedNCT05391698
This study is completed. It focuses on ADHD and currently lists study information in Greece.
In RethymnoADHDBehavioralFrom 9 Years to 12 Years
- Countries
- Greece
- Sponsor
- University of Crete
- Condition
- ADHD
CompletedNCT04473755
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In AmherstADHDOtherFrom 16 Years to 30 Years
- Countries
- United States
- Sponsor
- Florida International University
- Condition
- ADHD
CompletedNCT03233867
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In WayneADHDOtherFrom 6 Years to 17 Years
- Countries
- United States
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
- Condition
- ADHD
CompletedNCT02811211
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In WilmingtonADHDOtherFrom 6 Years to 17 Years
- Countries
- United States
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
- Condition
- ADHD
CompletedNCT05777785
This study is completed. It focuses on ADHD and currently lists study information in Israel.
In HaifaADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 40 Years
- Countries
- Israel
- Sponsor
- VIZO Specs Ltd
- Condition
- ADHD
CompletedNCT04002167
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In StanfordADHDBehavioralFrom 7 Years to 11 Years
- Countries
- United States
- Sponsor
- Stanford University
- Condition
- ADHD
CompletedNCT05835336
This study is completed. It focuses on ADHD and currently lists study information in Israel.
In HaifaADHDDeviceFrom 12 Years to 17 Years
- Countries
- Israel
- Sponsor
- VIZO Specs Ltd
- Condition
- ADHD
CompletedNCT04571320
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In SeattleADHDBehavioralFrom 13 Years to 16 Years
- Countries
- United States
- Sponsor
- Seattle Children's Hospital
- Condition
- ADHD
TerminatedNCT02827513
This study has public registry information in Australia. It focuses on ADHD.
In MelbourneADHDDrugA study involving a medication or substance.From 18 Years to 45 Years
- Countries
- Australia
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
TerminatedNCT06673368
This study has public registry information in the United States. It focuses on ADHD.
Multiple locations, including MaitlandADHDDrugFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- Neurocentria, Inc.
- Condition
- ADHD
OngoingEUCTR 2018-000821-29
This study is ongoing in the United Kingdom, in Belgium, in Germany, .... It focuses on ADHD.
In GermanyADHDOther
- Countries
- United Kingdom, Belgium, Germany, ...
- Sponsor
- Takeda Development Center Americas, Inc.
- Condition
- ADHD
CompletedNCT01886469
This study is completed in Canada. It focuses on ADHD.
In SaskatoonADHDDrugFrom 6 Years to 17 Years
- Countries
- Canada
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
- Condition
- ADHD
